Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Researcher

Wenji Yan

Chinese General Hospital College of Nursing and Liberal Arts

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 10, 2026 · JOURNAL ARTICLE

Case Report: Successful trastuzumab deruxtecan rechallenge after disease progression in a pretreated HER2-mutated lung adenocarcinoma patient

Frontiers in Oncology

A single case report of T-DXd rechallenge in HER2-mutant lung cancer showing clinical benefit; interesting but cannot establish efficacy or safety generalizable to practice without prospective data.

PreliminaryY Hu Lung Cancer Treatments and Mutations Chang Liu

Reported

Progression-free survival on rech…14 months

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support